Cowealth Medical Holding Co., Ltd. (TPEX:4745)
Taiwan · Delayed Price · Currency is TWD 10.40
-0.40 (-3.70%)
Jul 30, 2026, 1:30 PM CST
Cowealth Medical Holding Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 830 | 1,963 | 1,584 | 1,998 | 1,925 | 2,060 | |
Market Cap Growth | -34.49% | 23.96% | -20.74% | 3.82% | -6.58% | -16.22% |
Enterprise Value | 2,869 | 3,321 | 3,815 | 4,006 | 4,124 | 3,260 |
Last Close Price | 10.80 | 25.35 | 20.45 | 25.36 | 23.08 | 23.36 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 2518.03 | 40.69 | 20.45 | 14.77 |
Forward PE | - | 14.84 | 14.84 | 14.84 | 14.84 | 9.01 |
PS Ratio | 0.29 | 0.66 | 0.38 | 0.42 | 0.34 | 0.40 |
PB Ratio | 0.16 | 0.39 | 0.31 | 0.40 | 0.37 | 0.58 |
P/TBV Ratio | 0.29 | 0.69 | 0.57 | 0.75 | 0.68 | 0.80 |
P/FCF Ratio | - | 303.74 | 3.85 | - | - | - |
P/OCF Ratio | - | 126.42 | 3.37 | 44.38 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.00 | 1.12 | 0.91 | 0.83 | 0.73 | 0.63 |
EV/EBITDA Ratio | - | - | 29.31 | 12.69 | 10.17 | 8.39 |
EV/EBIT Ratio | - | - | 39.27 | 15.17 | 11.15 | 9.59 |
EV/FCF Ratio | - | 513.82 | 9.26 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.15 | 0.10 | 0.10 | 0.13 | 0.13 | 0.26 |
Debt / EBITDA Ratio | - | - | 3.64 | 2.05 | 1.63 | 2.24 |
Debt / FCF Ratio | - | 80.40 | 1.25 | - | - | - |
Net Debt / Equity Ratio | -0.04 | -0.12 | -0.14 | -0.06 | -0.14 | 0.02 |
Net Debt / EBITDA Ratio | 0.78 | 2.55 | -5.52 | -0.89 | -1.81 | 0.18 |
Net Debt / FCF Ratio | 0.47 | -95.36 | -1.74 | 1.74 | 2.57 | -0.46 |
Asset Turnover | 0.40 | 0.42 | 0.62 | 0.70 | 0.89 | 0.95 |
Inventory Turnover | 2.46 | 2.51 | 3.02 | 3.05 | 3.72 | 4.65 |
Quick Ratio | 2.15 | 2.21 | 2.64 | 2.75 | 2.51 | 2.02 |
Current Ratio | 2.74 | 2.79 | 3.39 | 3.60 | 3.34 | 2.75 |
Return on Equity (ROE) | -6.46% | -6.46% | 0.94% | 2.71% | 5.39% | 6.21% |
Return on Assets (ROA) | -2.40% | -2.46% | 0.89% | 2.39% | 3.67% | 3.94% |
Return on Invested Capital (ROIC) | -5.92% | -6.18% | 1.14% | 3.08% | 5.56% | 6.45% |
Return on Capital Employed (ROCE) | -5.40% | -5.40% | 1.90% | 5.20% | 7.00% | 9.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -29.81% | -12.56% | 0.04% | 2.46% | 4.89% | 6.77% |
FCF Yield | -49.31% | 0.33% | 26.01% | -8.07% | -14.87% | -7.42% |
Dividend Yield | - | - | - | 1.58% | 6.93% | 6.42% |
Payout Ratio | - | - | 4925.28% | 252.34% | 123.44% | 66.64% |
Buyback Yield / Dilution | 0.00% | - | 0.03% | 0.02% | 0.02% | -0.02% |
Total Shareholder Return | 0.00% | - | 0.03% | 1.60% | 6.95% | 6.40% |